Today, the American Society of Addiction Medicine (ASAM) released its new ASAM National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use.
Representatives from the National Association of Addiction Treatment Providers (NAATP), National Institute of Health (NIH) / National Institute on Drug Abuse (NIDA), Substance Abuse and Mental Health Services Administration (SAMHSA), and the Office of National Drug Control Policy (ONDCP) were represented at the event in The National Press Club in Washington.
Following a panel presentation of the Guideline, attendees participated in discussion regarding the dissemination to and use of the Guideline by addiction treatment providers. Among the comments, NAATP stressed its strong belief that the guideline section titled Psychosocial Treatment in Conjunction with Medications for the Treatment of OUD must be emphasized.
The ASAM materials released in conjunction with the event include The Guideline and the research article appearing in the Journal of Addiction Medicine.